The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

However, a new discovery by scientists at the Francis Crick Institute may offer a new way to treat this aggressive cancer.

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

Feb. 18, 2025 — Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis.

Some colorectal and pancreatic cancers may be resistant to KRAS G12C inhibitors due to co-occurring genetic alterations, according to a study published in the AACR journal Clinical Cancer Research.